世界の緑内障治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glaucoma Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2583 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、緑内障治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロスタグランジン類似体、ベータ遮断薬、アルファアゴニスト、炭酸脱水酵素阻害剤）、用途別市場規模（眼科クリニック、病院、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・緑内障治療の市場動向 ・企業の競争状況、市場シェア ・緑内障治療の種類別市場規模（プロスタグランジン類似体、ベータ遮断薬、アルファアゴニスト、炭酸脱水酵素阻害剤） ・緑内障治療の用途別市場規模（眼科クリニック、病院、外来手術センター） ・緑内障治療の北米市場規模2016-2027（アメリカ、カナダ） ・緑内障治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・緑内障治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・緑内障治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・緑内障治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Pfizer、Novartis、Merck） ・結論

Glaucoma is chronic, degenerative disorder that damages the eye’s optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics globally.
The change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period. Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market.

Market Analysis and Insights: Global Glaucoma Therapeutics Market
The global Glaucoma Therapeutics market size is projected to reach US$ 7817.9 million by 2026, from US$ 5556.7 million in 2019, at a CAGR of 4.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glaucoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glaucoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glaucoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glaucoma Therapeutics market.

Global Glaucoma Therapeutics Scope and Market Size
Glaucoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glaucoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors

Segment by Application
Ophthalmic Clinic
Hospitals
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Pfizer
Novartis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glaucoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prostaglandin Analogs
1.2.3 Beta Blockers
1.2.4 Alpha Agonists
1.2.5 Carbonic Anhydrase Inhibitors
1.3 Market by Application
1.3.1 Global Glaucoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ophthalmic Clinic
1.3.3 Hospitals
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glaucoma Therapeutics Market Perspective (2016-2027)
2.2 Glaucoma Therapeutics Growth Trends by Regions
2.2.1 Glaucoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glaucoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Glaucoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Glaucoma Therapeutics Industry Dynamic
2.3.1 Glaucoma Therapeutics Market Trends
2.3.2 Glaucoma Therapeutics Market Drivers
2.3.3 Glaucoma Therapeutics Market Challenges
2.3.4 Glaucoma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glaucoma Therapeutics Players by Revenue
3.1.1 Global Top Glaucoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Glaucoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glaucoma Therapeutics Revenue
3.4 Global Glaucoma Therapeutics Market Concentration Ratio
3.4.1 Global Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glaucoma Therapeutics Revenue in 2020
3.5 Glaucoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Glaucoma Therapeutics Product Solution and Service
3.7 Date of Enter into Glaucoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glaucoma Therapeutics Breakdown Data by Type
4.1 Global Glaucoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Glaucoma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Glaucoma Therapeutics Breakdown Data by Application
5.1 Global Glaucoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Glaucoma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glaucoma Therapeutics Market Size (2016-2027)
6.2 North America Glaucoma Therapeutics Market Size by Type
6.2.1 North America Glaucoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Glaucoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Glaucoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Glaucoma Therapeutics Market Size by Application
6.3.1 North America Glaucoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Glaucoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Glaucoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Glaucoma Therapeutics Market Size by Country
6.4.1 North America Glaucoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Glaucoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Glaucoma Therapeutics Market Size (2016-2027)
7.2 Europe Glaucoma Therapeutics Market Size by Type
7.2.1 Europe Glaucoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Glaucoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Glaucoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Glaucoma Therapeutics Market Size by Application
7.3.1 Europe Glaucoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Glaucoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Glaucoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Glaucoma Therapeutics Market Size by Country
7.4.1 Europe Glaucoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Glaucoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glaucoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Glaucoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Glaucoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glaucoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glaucoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Glaucoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Glaucoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glaucoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glaucoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Glaucoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Glaucoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glaucoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glaucoma Therapeutics Market Size (2016-2027)
9.2 Latin America Glaucoma Therapeutics Market Size by Type
9.2.1 Latin America Glaucoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Glaucoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Glaucoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Glaucoma Therapeutics Market Size by Application
9.3.1 Latin America Glaucoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Glaucoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Glaucoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Glaucoma Therapeutics Market Size by Country
9.4.1 Latin America Glaucoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Glaucoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glaucoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Glaucoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Glaucoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glaucoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glaucoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Glaucoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Glaucoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glaucoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glaucoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Glaucoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Glaucoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glaucoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Glaucoma Therapeutics Introduction
11.1.4 Allergan Revenue in Glaucoma Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Glaucoma Therapeutics Introduction
11.2.4 Pfizer Revenue in Glaucoma Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Glaucoma Therapeutics Introduction
11.3.4 Novartis Revenue in Glaucoma Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Glaucoma Therapeutics Introduction
11.4.4 Merck Revenue in Glaucoma Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prostaglandin Analogs
Table 3. Key Players of Beta Blockers
Table 4. Key Players of Alpha Agonists
Table 5. Key Players of Carbonic Anhydrase Inhibitors
Table 6. Global Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Glaucoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Glaucoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Glaucoma Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Glaucoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Glaucoma Therapeutics Market Share by Regions (2022-2027)
Table 12. Glaucoma Therapeutics Market Trends
Table 13. Glaucoma Therapeutics Market Drivers
Table 14. Glaucoma Therapeutics Market Challenges
Table 15. Glaucoma Therapeutics Market Restraints
Table 16. Global Glaucoma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Glaucoma Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Therapeutics as of 2020)
Table 19. Ranking of Global Top Glaucoma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Glaucoma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Glaucoma Therapeutics Product Solution and Service
Table 23. Date of Enter into Glaucoma Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Glaucoma Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Glaucoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Glaucoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Glaucoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Glaucoma Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Glaucoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Glaucoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Glaucoma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Glaucoma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glaucoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glaucoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glaucoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Glaucoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Glaucoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Glaucoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Glaucoma Therapeutics Product
Table 66. Allergan Revenue in Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Glaucoma Therapeutics Product
Table 71. Pfizer Revenue in Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Glaucoma Therapeutics Product
Table 76. Novartis Revenue in Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Glaucoma Therapeutics Product
Table 81. Merck Revenue in Glaucoma Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glaucoma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Prostaglandin Analogs Features
Figure 3. Beta Blockers Features
Figure 4. Alpha Agonists Features
Figure 5. Carbonic Anhydrase Inhibitors Features
Figure 6. Global Glaucoma Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Ophthalmic Clinic Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Glaucoma Therapeutics Report Years Considered
Figure 11. Global Glaucoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Glaucoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Glaucoma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Glaucoma Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Glaucoma Therapeutics Market Share by Players in 2020
Figure 16. Global Top Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Glaucoma Therapeutics Revenue in 2020
Figure 18. Global Glaucoma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Glaucoma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Glaucoma Therapeutics Market Share by Region (2016-2027)
Figure 40. China Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Glaucoma Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Glaucoma Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Glaucoma Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Glaucoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Revenue Growth Rate in Glaucoma Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Glaucoma Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Glaucoma Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Glaucoma Therapeutics Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---